In the five years to 2015, the Biological and Biochemical Product Manufacturing industry has been growing 21.5% per year to total $52.1 billion in 2015. The industry has benefited from the rapid development of the national economy, rising household disposable incomes and increasing investment in the healthcare sector by the Chinese government. Improvements in China's social security system, the establishment of a public health system establishment and the formation of the new rural cooperative medical care system have driven up demand for various industry products, particularly vaccines.
The Biological and Biochemical Product Manufacturing industry manufactures biological and biochemical products and genetically engineered drugs such as vaccines, blood products, and diagnostic reagents.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.